EUCTR2014-000815-15-IT进行中（未招募）不适用
Effects of a late add-on therapy of pegylated interferon (peg-IFNA) to ongoing nucleos(t)ideanalogs (NUCs) in patients with chronic hepatitis B (CHB).
Azienda Ospedaliera, Polo Universitario Luigi Sacco, Milano0 个研究点目标入组 40 人开始时间: 2014年12月22日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •age 18-65 years
- •HBsAg positivity
- •treatment with NUCs for at least 2 years;
- •compensated liver disease;
- •Hb > 12 g/dl
- •WBC > 3000/mm3
- •PLT >100000
- •ANA, AMA, ASMA, LKM-Ab negativity
- •HCV-Ab and HIV-Ab negative;
- •Signed informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •HCV or HIV coinfection;
- •Other liver diseases besides chronic hepatitis B fuori dell’epatite B;
- •decompensated liver disease;
- •Autoimmunity;
- •Major depression
- •hypersensitivity to Pegylated interferon
- •Uncontrolled pilepsy
研究者
相似试验
已完成
不适用
sefulness of Add-on Therapy of Pegylated Interferon alfa2a with Nucleoside/nucleotide Analog Treatment for Patients with Hepatitis B Virus InfectioChronic Hepatitis BJPRN-UMIN000032717Saitama Medical University, Department of Gastroenterology & Hepatology26
招募中
不适用
Effect of combination therapy of Pegylated interferon- Alpha 2a, Sofosbuvir and Ribavirin for 12 weeks versus combination of Sofosbuvir and Ribavirin for 24 weeks on viral loads in HCV Genotype 3 chronic hepatitis & compensated cirrhosis patientsHCV genotype 3 related chronic hepatitis & compensated cirrhosisSLCTR/2017/007Department of Hepatology Bangabandhu Sheikh Mujib Medical University
尚未招募
不适用
Effect of tablet Targlut on blood sugar controlCTRI/2023/02/049986Composite Interceptive Med Science Laboratories Pvt. Ltd,
未知
不适用
Efficacy of long term combination therapy of PEG-IFN-alpha-2b and Ribavirin for patients with chronic hepatitis CJPRN-C000000235Department of Hepatology, Graduate School of Medicine, Osaka City University300
已完成
3 期
Effectiveness and Side Effects of Pegylated Interferon Alpha-2a (Pegaferon®) Plus Ribavirin in the Patients With Chronic Hepatitis CHepatitis CNCT00527540Tehran Hepatitis Center60